Shaping the Future of Thrombus Removal With Lightning Bolt™ 7 and Lightning Flash™ 2.0: The Next Generation of Computer Assisted Vacuum Thrombectomy (CAVT™) – Endovascular Today
Designed for SPEED, SAFETY, and SIMPLICITY
Related Articles
لعلاج المصابين بعيوب قلبية.. مجدي يعقوب يبتكر صمامات قلب طبيعية «تدوم مدى الحياة» | المصري اليوم
في خطوة طبية وصفت بالثورية، كشف الجراح العالمي السير «مجدي يعقوب»، عن ابتكار جديد قد يُحدث تحولًا كبيراً في علاج أمراض القلب. يتناول الابتكار صمامات…
ACC Announces 2025 Distinguished Award Recipients – American College of Cardiology
The ACC is pleased to announce the recipients of its 2025 Distinguished Awards. This year’s honorees represent an inspiring group of individuals who hav e…
A snowstorm’s a-brewing — be careful out there to stay heart-healthy
DALLAS, Jan. 2, 2025 — Walking in a winter wonderland may sound serene and peaceful, however, shoveling your sidewalks to take that walk could quickly…
CES 2025: Cardiologist check-ups, AI-powered smart mirrors coming to heart patients’ homes
Healthcare companies from all over the world are showing off their newest cardiovascular offerings at CES 2025 in Las Vegas.
Cardiology Grand Rounds Speaker Diversity
This cross-sectional study examines data for grand rounds lectures at 42 US institutions to gauge the representation of women among cardiology grand rounds speakers.
Extended Rhythm Monitoring to Assess for Ventricular Arrhythmias After Transcatheter Pulmonary Valve Replacement With the Harmony Valve | Circulation: Cardiovascular Interventions
BACKGROUND: Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding…
Adipokines and Transitions in Metabolic Health Over Time: The Atherosclerosis Risk In Communities (ARIC) Study
AbstractContext. Transitions in metabolic health status over time are strongly linked to risk for cardiovascular events, particularly among individuals wit
Discussion Guides – SGLT2 Inhibitors | CardioSmart – American College of Cardiology
Use this resource to help optimize SGLT2 inhibitor use to improve outcomes in patients with heart failure, diabetes and chronic kidney disease.
Healthcare resource utilization and costs after initiating direct-acting oral anticoagulants or low molecular weight heparins in patients with venous thromboembolism – Godwin Okoye, Kenechukwu C Ben-Umeh, Anton LV Avanceña, Eberechukwu Onukwugha, 2025
Background: Venous thromboembolism (VTE) can lead to significant healthcare resource utilization (HcRU) and costs. First-line treatments such as direct-acting o…
TCTMD’s Biggest News of 2024: Stories, Videos, and More
Sugar substitutes, substance abuse, GLP-1 drugs, and the biggest clinical trials of the year—each had their place in our top 10.
